Borys D, Smulders R, Haranaka M, Nakano T, et al. Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naive Japanese adults: A phase 1 randomized dose-escalation trial. Vaccine 2024;44:126545.
PMID: 39612802